Next pandemic could be 'more contagious, or more lethal, or both,' vaccine co-creator warns

  • In Health
  • 2021-12-06 11:25:22Z
  • By NBC News

LONDON - One of the scientists behind the Oxford-AstraZeneca Covid-19 vaccine on Monday warned that the next pandemic could be even more deadly than the current one.

Professor Sarah Gilbert, an Oxford University academic who won acclaim for her role in developing a safe and effective Covid-19 vaccine in less than a year, warned against complacency in tackling future threats.

"This will not be the last time a virus threatens our lives and our livelihoods," she said in a lecture at Oxford University due to be broadcast by the BBC on Monday night. "The truth is, the next one could be worse. It could be more contagious, or more lethal, or both."

Professor Dame Sarah Gilbert speaking in a lecture to be broadcast Monday (BBC)
Professor Dame Sarah Gilbert speaking in a lecture to be broadcast Monday (BBC)  

In comments shared with news media in advance, she argued that the global pandemic shows the importance of being prepared for the next health emergency: "The advances we have made, and the knowledge we have gained, must not be lost."

The experts who worked to develop vaccines "must not now be asked to fade back into patient and under-funded obscurity," Gilbert added.

Covid-19 has killed more than 5 million people across the world, including almost 800,000 in the United States.

The Oxford-AstraZeneca vaccine was approved by the U.K. in December 2020 and is in use in more than 50 countries, but it has yet to be approved for use in the U.S. despite positive trial data.

President Joe Biden pledged in April to send 60 million doses of the vaccine to other countries.

On the current threat from the emerging Omicron variant - which was has been detected in at least 16 U.S. states according to NBC News' tally - Gilbert said that its mutations were known to increase transmissibility, while immunities gained through vaccines or prior infection could be less effective against it.

"But as we have seen before, reduced protection against infection and mild disease does not necessarily mean reduced protection against severe disease and death," she said.

Image: People walk past a Selfridge
Image: People walk past a Selfridge's store on Oxford Street, amid the COVID-19 outbreak in London (Henry Nicholls / Reuters)  

The Delta variant remains by far the most dominant form of the virus in the U.S., accounting for 99.9 percent of cases, Rochelle Walensky, director of the Centers for Disease Control and Prevention, told NBC News Friday.

Gilbert wrote about the vaccine's development in "Vaxxers: The Inside Story of the Oxford AstraZeneca Vaccine and the Race Against the Virus," a book co-authored with Professor Catherine Green in July.

Gilbert was delivering the annual Richard Dimbleby Lecture, named after a pioneering BBC broadcaster who died in 1965, where an expert in business, science or politics explains a topical issue.

Previous speakers include World Wide Web inventor Tim Berners-Lee, European Central Bank chief Christine Lagarde and Bill Gates.


More Related News

John Deere Is Facing a Farmer Revolt
John Deere Is Facing a Farmer Revolt

(Bloomberg) -- Farm equipment giant John Deere boasted record profits in 2021 as the global pandemic made consumers and countries more reliant than ever on a functioning agricultural sector. Also last year, unionized workers demanded a piece of the company's growing pie, and after a strike forced John Deere to provide better compensation to the men and women who make its products.Most Read from BloombergEarly Omicron Breakthroughs Show mRNA Vaccines' WeaknessWhy Some Vaccinated People Resist Omi

'Spending more and getting less': How the pandemic, inflation take a financial toll on families

Americans discuss how they're coping with price increases spurred by COVID-19. And even while they tighten budgets, inflation means they spend more.

People that suffered only mild COVID-19 still had memory and concentration problems, with some experiencing issues 9 months later, a study found
People that suffered only mild COVID-19 still had memory and concentration problems, with some experiencing issues 9 months later, a study found

An Oxford University study found that people who recovered from mild COVID-19 had worse cognitive performance than those who hadn't had the virus.

Novavax becomes Australia
Novavax becomes Australia's 5th approved COVID-19 vaccine

Novavax's COVID-19 vaccine on Thursday became the fifth coronavirus vaccine approved for use in Australia. The country has ordered 51 million doses of the U.S.-manufactured vaccine, supplied under the brand Nuvaxovid, for its population of 26 million. Pfizer, AstraZeneca and Moderna vaccines are already in use in Australia.

Pfizer chief Albert Bourla wins $1 million Genesis Prize
Pfizer chief Albert Bourla wins $1 million Genesis Prize

Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded on Wednesday the prestigious Genesis Prize for his efforts in leading the development of a COVID-19 vaccine. The Genesis Prize Foundation said Bourla had received the largest number of votes in an online campaign in which some 200,000 people in 71 countries participated. It cited Pfizer's decision to turn down U.S. government funding early in the pandemic, a decision that helped the company reduce bureaucracy and expedite development of the vaccine.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


Top News: Health